Intratumoral Vusolimogene Oderparepvec (VO) in Combination With Pembrolizumab for Angiosarcoma

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Intratumoral Vusolimogene Oderparepvec (VO) in Combination With Pembrolizumab for Angiosarcoma	Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, angiosarcoma, neoplasm, sarcoma, vascular cancer	Recruiting	Phase 2	2026-09-01		NCT06898970

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Replimune, Inc.	14
Varun Monga, MBBS	2

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
University of California, San Francisco	San Francisco	United States	294

Clinical trials